USNU — Elite Health Systems Share Price
Last trade - 00:00- $17.77m
- $13.74m
- 63
- 21
- 66
- 48
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 4.25 | ||
| Price to Tang. Book | 4.25 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | n/a | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -42.42% | ||
| Return on Equity | -85.22% | ||
| Operating Margin | n/a | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 3.17 | 1.06 | n/a | n/a | n/a | n/a | n/a | -100% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +275.41 | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Elite Health Systems Inc. through its wholly owned subsidiaries, is developing a business to provide Medicare Advantage plans and related services. Medicare Advantage is the federal health insurance program for people aged 65 and over, which has been expanded to cover people under 65 with certain disabilities and people with end-stage renal disease requiring dialysis or kidney transplant. The Company’s wholly owned subsidiary, Elite Health Systems Holdings Inc. (EHSH), and wholly owned subsidiaries of EHSH, including Elite Health Plan, Inc. and Elite Health Plan of Nevada, Inc., are collectively referred to as Elite Health. Elite Health is engaged in identifying a network of providers who are well-versed in Medicare Advantage plans and addressing the healthcare needs of seniors in the communities.
Directors
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- August 21st, 2015
- Public Since
- October 21st, 1999
- No. of Shareholders
- 122
- No. of Employees
- 3
- Sector
- Healthcare Providers & Services
- Industry
- Healthcare
- Exchange
- Pink Sheets on Nasdaq
- Shares in Issue
- 21,409,924
- Address
- 1131 W 6TH STREET, SUITE 225, ONTARIO, 91762
- Web
- http://www.elitehealthsystems.com/
- Phone
- +1 9492491170
- Auditors
- Mercurious & Associates LLP
Upcoming Events for USNU
Similar to USNU
4Cable TV International
Pink Sheets on Nasdaq
Abattis Bioceuticals
Pink Sheets on Nasdaq
Accelera Innovations
Pink Sheets on Nasdaq
Quantum Medical Transport
Pink Sheets on Nasdaq
Aesthetic Medical International Holdings
Pink Sheets on Nasdaq
FAQ
As of Today at 23:54 UTC, shares in Elite Health Systems are trading at $0.83. This share price information is delayed by 15 minutes.
Shares in Elite Health Systems last closed at $0.83 and the price had moved by +16.25% over the past 365 days. In terms of relative price strength the Elite Health Systems share price has outperformed the S&P500 Index by +8.61% over the past year.
There is no consensus recommendation for this security.
Find out moreElite Health Systems does not currently pay a dividend.
Elite Health Systems does not currently pay a dividend.
Elite Health Systems does not currently pay a dividend.
To buy shares in Elite Health Systems you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $0.83, shares in Elite Health Systems had a market capitalisation of $17.77m.
Here are the trading details for Elite Health Systems:
- Country of listing: United States
- Exchange: PNK
- Ticker Symbol: USNU
Based on an overall assessment of its quality, value and momentum Elite Health Systems is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Elite Health Systems. Over the past six months, its share price has outperformed the S&P500 Index by +22.74%.
As of the last closing price of $0.83, shares in Elite Health Systems were trading +22.17% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Elite Health Systems PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $0.83.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on Elite Health Systems' directors